-- Scott Roberts
THURSDAY, Nov. 4 (HealthDay News) -- Ofirmev has been approved
by the U.S. Food and Drug Administration to treat fever and
mild-to-moderate pain, maker Cadence Pharmaceuticals said in a news
It's the first FDA-approved injected version of acetaminophen,
the San Diego company said. Acetaminophen is the active ingredient
Approval followed clinical studies involving 1,020 adults and
355 pediatric patients aged 2 and older. The drug's effectiveness
to treat pain and fever hasn't been studied in children younger
than 2, Cadence said.
The most common side effects of Ofirmev included nausea,
vomiting, headache, insomnia, constipation and agitation. The drug
shouldn't be used by people with active liver disease, alcoholism
or a known sensitivity to acetaminophen, the company said.
To learn more about acetaminophen, visit the
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.